发明名称 PROBIOTIC GRAM-POSITIVE BACTERIA FOR THE PROPHYLAXIS, SUPPRESSION, OR ELIMINATION OF ALLERGIC REACTIONS IN HUMAN
摘要 A method for a prophylaxis, suppression or elimination of an allergic reaction in a human, or for shifting the TH1-TH2 balance in a human body toward an increase of TH1 or a decrease of TH2 or both an increase in TH1 and a decrease in TH2, includes the steps of preparing a pharmaceutical composition having genomic DNA of at least one probiotic, gram-positive bacteria strain selected from the group Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5, Bifidobacterium bifidum MG 20/5, Bifidumbacterium longum SP 07/3, Lactobacillus rhamnosus GG (92164) or a combination thereof, as an active ingredient, the at least one probiotic, gram-positive bacteria strain being present in the form of at least one of viable bacteria and inactivated bacteria, and administering to a human as suppository, vaginally, as a cream applied to skin, rectally, as a subcutaneous injection, as intravenous injection, as an inhalation liquid, or orally in combination with food.
申请公布号 US2014288159(A1) 申请公布日期 2014.09.25
申请号 US201314089502 申请日期 2013.11.25
申请人 Schrezenmeir Jürgen 发明人 Schrezenmeir Jürgen
分类号 C12N15/11 主分类号 C12N15/11
代理机构 代理人
主权项 1. A method for a prophylaxis, suppression or elimination of an allergic reaction in a human, or for shifting the TH1-TH2 balance in a human body toward an increase of TH1 or a decrease of TH2 or both an increase in TH1 and a decrease in TH2, comprising the steps of: preparing a pharmaceutical composition comprising: genomic DNA of at least one probiotic, gram-positive bacteria strain selected from the group consisting of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5, Bifidobacterium bifidum MG 20/5, Bifidumbacterium longum SP 07/3, Lactobacillus rhamnosus GG (92164) and a combination thereof, as an active ingredient in said pharmaceutical composition, said at least one probiotic, gram-positive bacteria strain being present in the form of at least one of viable bacteria and inactivated bacteria; and, administering said pharmaceutical composition to a human via a suppository, vaginally, via a cream applied to skin, rectally, via a subcutaneous injection, via intravenous injection, via inhalation liquid and a combination thereof.
地址 Karlsruhe DE
您可能感兴趣的专利